Liaoning Grand Nuokang Biopharmaceutical Co., Ltd. Report issue

For profit
Founded: Liaoning China (1997)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.

Active Ingredients

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperphosphatemia (Phase 2)

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0